Integra LifeSciences Holdings Corporation

Financial

Josh SandbergAugust 4, 2015
977

Integra Tops Earnings & Revenues, Guides Low on Spine Sale

Integra LifeSciences Holdings Corporation (IART – Analyst Report) reported adjusted earnings per share (EPS) of 79 cents in the second quarter of 2015,…
Read More »
Financial

Josh SandbergJuly 16, 2015
895

INTEGRA LIFESCIENCES TO HOST ITS SECOND QUARTER 2015 EARNINGS RESULTS CONFERENCE CALL ON JULY 30, 2015

PLAINSBORO, N.J., July 15, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its second quarter 2015 financial results on…
Read More »
Financial

Josh SandbergJune 10, 2015
1,476

Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015

PLAINSBORO, N.J., June 9, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Board of Directors of Integra…
Read More »
Financial

Josh SandbergMay 21, 2015
1,083

Integra LifeSciences to Provide Historical Financials Adjusted for Discontinued Operations and Host Conference Call on May 26, 2015

PLAINSBORO, N.J., May 20, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to release historical financial information adjusted…
Read More »
Recon

Josh SandbergMay 1, 2015
2,094

Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine

PLAINSBORO, N.J., April 30, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation(Nasdaq:IART) today announced the appointment, effective May 1, 2015,…
Read More »
Financial

Josh SandbergApril 20, 2015
2,066

Integra Looks to Spin Off Spinal Surgical Business

By Fred Zucker Integra LifeSciences Holdings Corporation (NASDAQ: IART), a diversified medical technology company focused on surgical and tissue regeneration…
Read More »
Hospitals

Josh SandbergApril 1, 2015
1,734

Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine

PLAINSBORO, N.J., April 1, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the filing of an initial Form 10…
Read More »

Integra LifeSciences Holdings Corporation

INTEGRA LIFESCIENCES TO HOST ITS SECOND QUARTER 2015 EARNINGS RESULTS CONFERENCE CALL ON JULY 30, 2015

Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015

Integra LifeSciences to Provide Historical Financials Adjusted for Discontinued Operations and Host Conference Call on May 26, 2015

Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine

Integra Looks to Spin Off Spinal Surgical Business

Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

Four mega mergers helped increase M&A in Q1

Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.

Integra Tops Earnings & Revenues, Guides Low on Spine Sale

INTEGRA LIFESCIENCES TO HOST ITS SECOND QUARTER 2015 EARNINGS RESULTS CONFERENCE CALL ON JULY 30, 2015

Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015

Integra LifeSciences to Provide Historical Financials Adjusted for Discontinued Operations and Host Conference Call on May 26, 2015

Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine

Integra Looks to Spin Off Spinal Surgical Business

Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

Four mega mergers helped increase M&A in Q1

Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.